The role of angiogenesis in the accumulation of peritoneal fluid in benign conditions and the development of malignant ascites in the female

被引:34
作者
Sherer, DM
Eliakim, R
Abulafia, O
机构
[1] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Coll Phys & Surg, Dept Obstet & Gynecol,Div Maternal Fetal Med, New York, NY 10019 USA
[2] Rambam Univ Hosp, Div Gastroenterol, Haifa, Israel
[3] SUNY Brooklyn, Dept Obstet & Gynecol, Div Gynecol Oncol, Brooklyn, NY USA
关键词
angiogenesis; vascular endothelial growth factor; ascites; peritoneal fluid; malignancy;
D O I
10.1159/000010320
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Our objective was to present current data pertaining to the role of angiogenesis in the accumulation of peritoneal fluid in both benign conditions and in the development of malignant ascites in the female. To this goal, we conducted a computerized search to identify all relevant studies published in the English literature. MEDLINE, Current Contents and Index Medicus were searched utilizing the terms: angiogenesis, peritoneal fluid, ascites, vascular endothelial growth factor (VEGF), therapy and carcinoma through May 2000. Review of the literature supports that angiogenesis promoted by VEGF is associated with fluid accumulation in animal and human tumor effusions. Benign conditions involving accumulation of peritoneal fluid and associated angiogenesis in the female include ovulation, endometriosis and severe ovarian hyperstimulation syndrome. Malignant intra-abdominal conditions associated with increased VEGF activity include primary epithelial ovarian, gastric and colon carcinomas, omental and hepatic metastatic disease. initial trials with antiangiogenic (angioinhibitor) therapy such as anti-VEGF antibodies, anti-VEGF receptor antibodies, tumor necrosis factor, and metalloproteinase inhibitors have been reported and antitumor activity observed in a limited number of patients with advanced (inoperable or metastatic) disease. Copyright (C) 2000 S. Karger. AG, Basel.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 65 条
[1]  
ABDULLAH HI, 1997, RISK B INFERTILITY D
[2]  
Abramov Y, 1996, HUM REPROD, V11, P1381
[3]   Angiogenesis of the ovary [J].
Abulafia, O ;
Sherer, DM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (01) :240-246
[4]  
Beattie GJ, 1998, CLIN CANCER RES, V4, P1899
[5]   Tumor necrosis factor effects on ascites formation in an experimental tumor model [J].
Behammer, W ;
Kluge, M ;
Ruschoff, J ;
Mannel, DN .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1996, 16 (05) :403-408
[6]  
DONNEZ J, 1982, OBSTET GYNECOL, V59, P687
[7]   The role of αv integrins during angiogenesis [J].
Eliceiri, BP ;
Cheresh, DA .
MOLECULAR MEDICINE, 1998, 4 (12) :741-750
[8]   High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata [J].
Fasciani, A ;
D'Ambrogio, G ;
Bocci, G ;
Monti, M ;
Genazzani, AR ;
Artini, PG .
MOLECULAR HUMAN REPRODUCTION, 2000, 6 (01) :50-54
[9]  
FELDMAN GB, 1972, CANCER RES, V32, P1663
[10]   LYMPHATIC DRAINAGE OF PERITONEAL CAVITY AND ITS SIGNIFICANCE IN OVARIAN CANCER [J].
FELDMAN, GB ;
KNAPP, RC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1974, 119 (07) :991-994